Hull, R D <br/><br/>
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.  [electronic resource] 

 -  Archives of internal medicine  Feb 1997 
 - 289-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-9926 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--administration & dosage<br/>Bias<br/>Canada<br/>Cost-Benefit Analysis<br/>Drug Administration Schedule<br/>Heparin--administration & dosage<br/>Heparin, Low-Molecular-Weight--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Sensitivity and Specificity<br/>Thromboembolism--etiology<br/>Thrombosis--complications<br/>United States